Aligos Therapeutics, Inc. short interest in 2023
In 2023, Aligos Therapeutics, Inc.'s disclosed short interest ran from 0.75% of shares outstanding on 13 Jan 2023 to 1.14% on 29 Dec 2023, a change of +0.39 percentage points. The year's high was 2.14% on 31 May 2023 and its low 0.75% on 13 Jan 2023, averaging 1.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.82 days on 31 Aug 2023. Full history: Aligos Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.75% (13 Jan 2023)
- End of year
- 1.14% (29 Dec 2023)
- Change
- +0.39 pp
- High
- 2.14% (31 May 2023)
- Low
- 0.75% (13 Jan 2023)
- Average
- 1.62%
- Highest days to cover
- 19.82 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.75% | 1.00 | |
| 31 Jan 2023 | 1.71% | 1.00 | |
| 15 Feb 2023 | 1.72% | 4.16 | |
| 28 Feb 2023 | 1.99% | 8.48 | |
| 15 Mar 2023 | 2.03% | 6.19 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 1.94% | 7.69 | |
| 14 Apr 2023 | 1.81% | 13.42 | |
| 28 Apr 2023 | 1.80% | 9.00 | |
| 15 May 2023 | 1.71% | 1.16 | 10-Q filed, results (8-K) |
| 31 May 2023 | 2.14% | 5.32 | |
| 15 Jun 2023 | 1.83% | 9.42 | |
| 30 Jun 2023 | 1.90% | 3.55 | |
| 14 Jul 2023 | 1.87% | 7.14 | |
| 31 Jul 2023 | 1.79% | 9.37 | |
| 15 Aug 2023 | 1.71% | 8.15 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.75% | 19.82 | |
| 15 Sep 2023 | 1.76% | 15.80 | |
| 29 Sep 2023 | 1.73% | 16.54 | |
| 13 Oct 2023 | 1.75% | 12.99 | |
| 31 Oct 2023 | 0.98% | 5.20 | |
| 15 Nov 2023 | 0.97% | 5.66 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 1.01% | 15.09 | |
| 15 Dec 2023 | 1.15% | 1.33 | |
| 29 Dec 2023 | 1.14% | 1.39 |
See also: Aligos Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.